About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 7364 record(s)
Req # A-2024-000007
Adverse Drug Reactions (ADRs) for Heparin. Report numbers: 001072985.Organization: Health Canada
April 2024
Req # A-2024-000012
Adverse Drug Reactions (ADRs). Report numbers: 001067949, 001069982.Organization: Health Canada
April 2024
Req # A-2024-000017
Adverse Drug Reaction (ADR) for ACITRETIN. Report number: 1071472. ADRs for ANASTROZOLE. Report numbers: 983160, 990116. ADR for CIPROFLOX. Report number: 1032025. ADR for Clonidine. Report number: 981372. ADRs for EPLERENONE. Reports number:…Organization: Health Canada
April 2024
Req # A-2024-000028
Adverse Drug Reactions (ADRs) for Rosuvastatin-40. Report numbers: 000657015, 000702528. ADRs for Rosuvastatin-10. Report numbers: 000675846, 000928844. ADRs for Rosuvastatin-5. Report numbers: 000698101, 000705573. ADRs for Rosuvastatin-20.…Organization: Health Canada
April 2024
Req # A-2024-000032
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001049833, 001051635, 001052031, 001052040, 001052619, 001050859, 001053224, 001055320, 001065019, 001065607.Organization: Health Canada
April 2024
Req # A-2024-000068
Adverse Drug Reaction (ADR) for YESCARTA. Report number: 001076510.Organization: Health Canada
April 2024
Req # A-2022-00155
Briefing Note TAG20935: Follow-Up Letter to the Government of Nunavut.Organization: Crown-Indigenous Relations and Northern Affairs Canada
March 2024
Req # A-2022-00189
Documents pertaining to O’Chiese First Nation from specified volumes.Organization: Crown-Indigenous Relations and Northern Affairs Canada
March 2024
Req # A-2022-00205
Briefing Note MM2502: Meeting With The Missing And Murdered Indigenous Women, Girls and 2SLGBTQQIA+ People Urban Working Group, On January 30, 2023.Organization: Crown-Indigenous Relations and Northern Affairs Canada
March 2024
Req # A-2022-00217
Documents relating to the funding agreement submitted by the Assembly of First Nations to host and plan the First Nations First Responders Gathering in spring 2023.Organization: Crown-Indigenous Relations and Northern Affairs Canada
March 2024